https://european-biotechnology.net/wp-content/uploads/2025/05/EB225_Insight-DoubleValley_Scale-up-Strategy_tg-1030x550-1.png
550
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-05-30 07:13:382025-05-30 07:13:38EU set to improve investment for biotech start-ups and scale-ups
https://european-biotechnology.net/wp-content/uploads/2025/05/NoMy-e1748430078568-1030x579-1.webp
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-05-28 11:02:572025-05-28 11:02:57Norwegian Mycelium AS bags €1.25m to scale mycoprotein production
https://european-biotechnology.net/wp-content/uploads/2025/05/Nanopore1000_F_754527197_EzNeV1lcMHBGj3SfwrhQv27OR0CMo5Bt-e1748414774161.jpg
537
955
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-05-28 06:46:312025-05-28 06:46:31Reproducible nanopore sequencing to be commercialised from 2026
https://european-biotechnology.net/wp-content/uploads/2025/05/C4X-Discovery-e1748338419710-1030x581-1.png
581
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-05-27 09:34:312025-05-27 09:34:31C4X Discovery bags milestone for IL-17A blocker from Sanofi
https://european-biotechnology.net/wp-content/uploads/2025/05/Mitochondria_-Boontharika.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-05-26 11:56:162025-05-26 11:56:16New way to target mitochondrial diseases
https://european-biotechnology.net/wp-content/uploads/2025/05/Vicki-scaled-e1748162226781-1030x580-1.jpeg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-05-25 08:49:202025-05-25 08:49:20Biopharma transformation: leading drug discovery start-ups of 2025
https://european-biotechnology.net/wp-content/uploads/2025/05/TLM-Group-Photo-e1747314464657-1030x580-1.png
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-05-22 07:48:402025-05-22 07:48:40Countdown to SLAS Europe: ThirdLaw Molecular Inc.
https://european-biotechnology.net/wp-content/uploads/2025/05/ugur-sahin-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-05-22 05:25:172025-05-22 05:25:17BioNTech Secures £129m UK Backing
https://european-biotechnology.net/wp-content/uploads/2025/05/LifeTaq-scaled-e1747583489427-1030x580-1.jpg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-05-21 13:15:402025-05-21 13:15:40Countdown to SLAS Europe: LifeTaq Analytics GmbH
https://european-biotechnology.net/wp-content/uploads/2025/05/20250521-sv-health-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-05-21 08:35:002025-05-21 08:35:00SV Health Raises US$269m for Dementia Start-ups
Scroll to top
